NEW YORK (GenomeWeb News) – Complete Genomics said today that its revenues increased 74 percent year over year during the third quarter.

For the three months ended Sept. 30, revenues reached $7.3 million, compared to $4.2 million a year ago. Despite the spike, the Mountain View, Calif.-based company, which is in the process of being acquired by BGI-Shenzhen, missed the average analyst estimate of $8.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.